Research square · 2026
Disparities in Timeliness of Cancer Diagnosis Across a Multi-Site Academic Health System.
СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tran Vivian Hoang, Rajan Suraj Manohar, Dominguez Carol Y Ochoa, Demb Joshua, Parada Humberto, Martinez Elena, McDaniels Corinne, Crespo Noe, Schiaffino Melody K, Mehtsun Winta, Murphy James, Rose Brenton, Banegas Matthew P
Аннотация
BACKGROUND: Early cancer diagnosis improves survival and quality of life, yet disparities in stage at diagnosis persist. This study evaluates demographic, clinical, insurance, and neighborhood-level socioeconomic factors associated with late-stage cancer diagnosis within an academic health system.
METHODS: We conducted a retrospective cohort study of 27,064 adults diagnosed with breast, colorectal, or lung and bronchus cancer between 2015 and 2025 in the University of California Health System. Late-stage disease was defined as AJCC stage III/IV. Multivariable logistic regression examined associations between late-stage diagnosis and patient characteristics, insurance status, comorbidity burden, and neighborhood socioeconomic measures, including the Area Deprivation Index (ADI), Social Vulnerability Index (SVI), and Healthy Places Index (HPI).
RESULTS: 17.6% of patients were diagnosed at a late stage. Cancer type was the strongest predictor, with lung (aOR ≈ 13-14) and colorectal cancer (aOR ≈ 8) associated with higher odds of late-stage diagnosis compared with breast cancer. Residence in medium and high ADI tertiles and Medicaid insurance (OR = 1.16; 95% CI: 1.06-1.28) were associated with higher odds of late-stage diagnosis, while Veterans Affairs coverage was associated with lower odds (OR = 0.76; 95% CI: 0.58-1.01). SVI was not associated with stage at diagnosis, whereas higher HPI scores were modestly protective.
CONCLUSION: Late-stage cancer diagnosis is driven primarily by cancer type and insurance status, with additional contributions from neighborhood disadvantage.
METHODS: We conducted a retrospective cohort study of 27,064 adults diagnosed with breast, colorectal, or lung and bronchus cancer between 2015 and 2025 in the University of California Health System. Late-stage disease was defined as AJCC stage III/IV. Multivariable logistic regression examined associations between late-stage diagnosis and patient characteristics, insurance status, comorbidity burden, and neighborhood socioeconomic measures, including the Area Deprivation Index (ADI), Social Vulnerability Index (SVI), and Healthy Places Index (HPI).
RESULTS: 17.6% of patients were diagnosed at a late stage. Cancer type was the strongest predictor, with lung (aOR ≈ 13-14) and colorectal cancer (aOR ≈ 8) associated with higher odds of late-stage diagnosis compared with breast cancer. Residence in medium and high ADI tertiles and Medicaid insurance (OR = 1.16; 95% CI: 1.06-1.28) were associated with higher odds of late-stage diagnosis, while Veterans Affairs coverage was associated with lower odds (OR = 0.76; 95% CI: 0.58-1.01). SVI was not associated with stage at diagnosis, whereas higher HPI scores were modestly protective.
CONCLUSION: Late-stage cancer diagnosis is driven primarily by cancer type and insurance status, with additional contributions from neighborhood disadvantage.